Davion Healthcare PLC (DAVI) vs Harvard Bioscience, Inc. (HBIO)

Davion Healthcare PLC and Harvard Bioscience, Inc. are both Medical Instruments & Supplies companies. Harvard Bioscience, Inc. is the larger, with a market value of $38.5M against $32.8M — 1.2× the size.

Valuation

Metric DAVI HBIO Medical Instruments & Supplies median
P/E — n/m 30.28
P/S — 0.44 2.49
P/B — 5.22 2.34
Price to free cash flow — n/m 23.49
EV/EBITDA — 14.53 14.87
EV/Sales — 1.17 2.75
Earnings yield — (27.02%) 0.00%
Free cash flow yield — (4.73%) 0.59%

Profitability

Metric DAVI HBIO Medical Instruments & Supplies median
Gross margin — 58.16% 53.60%
Operating margin — (0.28%) 1.97%
Net margin — (11.86%) 0.00%
Free cash flow margin — (2.09%) 2.36%
Return on equity — (89.95%) 0.00%
Return on assets — (13.32%) 0.00%
Return on invested capital — (0.41%) 0.13%

Growth

Metric DAVI HBIO Medical Instruments & Supplies median
Revenue growth (TTM) — (1.06%) 8.97%
EPS growth (last fiscal year) — (357.14%) 6.51%
Revenue growth, 5-year CAGR — (3.25%) 8.85%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric DAVI HBIO Medical Instruments & Supplies median
Debt to equity — 4.95 0.10
Current ratio — 1.87 2.47
Net debt to EBITDA — 4.11 0.97

Dividend

Metric DAVI HBIO Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric DAVI HBIO Medical Instruments & Supplies median
Market cap 32.75m 38.52m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack